Filter
234
Filtered Results: 234
Text search:
vaccine
vial
monitor
Featured
Recommendations
40
New Publications
75
Language
Document type
No document type
107
Guidelines
70
Manuals
22
Studies & Reports
13
Fact sheets
10
Strategic & Response Plan
8
Training Material
2
Resource Platforms
1
Infographics
1
Countries / Regions
India
18
South Africa
11
Kenya
10
Uganda
10
Tanzania
6
Philippines
5
Global
5
Ethiopia
5
Nepal
4
Rwanda
4
Nigeria
4
Africa
4
Argentina
4
Zimbabwe
3
Latin America and the Carribbean
3
Liberia
3
Sierra Leone
2
Senegal
2
West and Central Africa
2
Bangladesh
2
Zambia
2
Myanmar / Burma
2
Cameroon
1
Syria
1
Burkina Faso
1
Afghanistan
1
Malawi
1
Guinea
1
Haiti
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Paraguay
1
United Kingdom
1
Brazil
1
Russia
1
Namibia
1
Yemen
1
Central African Republic
1
Mali
1
Libya
1
Botswana
1
South Sudan
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
94
Clinical Guidelines
39
Women & Child Health
20
Public Health
13
Key Resources
9
Capacity Building
4
Pharmacy & Technologies
4
Toolboxes
COVID-19
48
Pharmacy
25
Rapid Response
16
AMR
9
Ebola & Marburg
8
Polio
8
HIV
6
TB
5
Caregiver
4
NTDs
3
Natural Hazards
2
Cholera
2
NCDs
2
Conflict
2
Mental Health
1
Refugee
1
Planetary Health
1
Zika
1
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Updated 28 December 2020
10 December 2020
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
WHO Secretariat Information paper July 2016
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the...
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in children.
The WHO Guide on Oral Cholera Vaccines in Mass Immunization Campaigns provides guidance on the planning and implementation of oral cholera vaccine (OCV) campaigns. It covers key aspects such as when and where to use OCVs, vaccine specifications, and recommendations for use in endemic areas, outbreak...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
first issued 18 August 2022
Principles and Target Product Criteria. Roadmap January 12, 2015
The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality3 SIAs for injectable vaccines and highlight the opportunities to strengthen RI and surveillance. The guide uses measles–rubella SIAs as the main example throughout, but the informatio...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
